TRILL AB (CIK 1887436) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-08). Recent activity: Buy DMAC (187,393 shares), Buy DMAC (182,882 shares), Buy DMAC (240,352 shares), Buy DMAC (128,426 shares), Buy DMAC (208,872 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-08 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 187,393 | $1.2M |
| 2025-12-08 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 182,882 | $1.2M |
| 2025-12-08 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 240,352 | $1.7M |
| 2025-12-08 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 128,426 | $951,637 |
| 2025-12-08 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 208,872 | $1.5M |
| 2025-12-08 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 40,253 | $317,596 |
| 2025-12-08 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 73,099 | $626,458 |
| 2025-09-04 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 293,601 | $1.7M |
| 2025-09-04 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 70,414 | $421,780 |
| 2025-09-04 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 8,233 | $49,398 |
| 2025-09-04 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 71,107 | $416,687 |
| 2025-09-04 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 48,172 | $287,105 |
| 2025-09-04 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 59,788 | $356,336 |
| 2025-09-04 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 338,265 | $2.0M |
| 2025-09-04 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 59,648 | $357,888 |
| 2025-09-04 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 50,772 | $304,632 |
| 2025-07-25 | DiaMedica Therapeutics Inc. (DMAC) | 10% Owner | Buy | 1.5M | $5.4M |
来源：SEC Form 4 申报文件 · 截至 2025-12-08